Garuda - Garba Rujukan Digital

Identifikasi Interaksi Obat Pada Pasien Stroke di Unit Stroke Rumah Sakit Umum Daerah Banyumas SUHESTI, TUTI SRI; UTAMI, ESTI DYAH
Acta Pharmaciae Indonesia Vol 4 No 1 (2016)
Publisher : Pharmacy Department, Faculty of Health Sciences, Jenderal Soedirman University, Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (215.907 KB)

Pasien stroke sering memperoleh lebih dari dua macam obat sehingga meningkatkan kemungkinan terjadinya interaksi obat. Penelitian ini bertujuan untuk mengetahui kejadian interaksi obat pada pasien stroke rawat inap di unit stroke RSUD Banyumas berdasarkan buku Drug Interaction Facts. Penelitian ini merupakan penelitian deskriptif evaluatif yang bersifat retrospektif. Pengambilan sampel dilakukan secara total sampling. Data dianalisis secara deskriptif dan disajikan dalam bentuk data kuantitatif dan kualitatif. Hasil penelitian menunjukkan bahwa dari 62 pasien stroke terdapat 26% pasien yang mengalami interaksi obat. Jumlah interaksi obat yang paling banyak terjadi adalah 1 jenis interaksi obat (74%). Jenis interaksi obat yang sering terjadi pada pasien stroke yaitu interaksi obat antara Angiotensin Converting Enzyme Inhibitor (ACEI) dengan KCl sebanyak 18,18%. Mekanisme interaksi obat yang paling banyak terjadi adalah unknown (36%). Tingkat signifikansi 4 paling banyak terjadi yaitu 50%, dengan onset interaksi obat adalah delayed (57%) dan tingkat keparahan moderate yaitu sebanyak 57%. Dokumentasi interaksi obat yang paling banyak terjadi adalah possible (50%).

Disolusi Terbanding Tablet Acetaminophen Produk Generik Berlogo dan Produk Bermerek Suhesti, Tuti Sri; Nur Rachmani, EKA Prasasti
Acta Pharmaciae Indonesia Vol 6 No 2 (2018): Acta Pharmaciae Indonesia Volume 6 No.2 Tahun 2018
Publisher : Pharmacy Department, Faculty of Health Sciences, Jenderal Soedirman University, Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (197.028 KB)

Acetaminophen/parasetamol adalah obat analgetik-antipiretik yang populer dan banyak digunakan. Sediaan acetaminophen dalam bentuk tablet, selain dengan nama generik juga tersedia dengan nama dagang. Tujuan penelitian ini adalah untuk mengetahui ekivalensi in vitro terhadap mutu produk dagang dan generik berlogo tablet acetaminophen yang beredar di pasaran. Pada penelitian ini dilakukan uji disolusi terbanding acetaminophen produk obat generik berlogo dan produk bermerek dalam media disolusi berupa larutan dapar phosphat pH 5,8. Penentuan laju disolusi acetaminophen dilakukan menggunakan metode paddle (dayung) dengan kecepatan pengadukan 50 rpm, pada suhu 370C ± 0,50C. Sampel cuplikan diambil pada menit ke 5, 10, 15, 20, 30 dan 45. Parameter uji yang diamati adalah kadar obat terlarut pada saat t=30 menit (C30) dengan parameter standar baku C30 menunjukkan hasil tidak boleh kurang dari 80% kadar obat. Hasil penelitian didapatkan bahwa disolusi tablet acetaminophen masing-masing produk baik obat generik berlogo maupun produk bermerek menunjukkan gambaran profil disolusi yang berbeda. Dari 8 sampel diperoleh 5 produk paten dan 3 produk generik semuanya menunjukkan hasil disolusi dengan nilai C30 yang memenuhi syarat (>80)

Optimization of piroxicam tablet formula using flowlac, avicel and compritol by Simplex Lattice Design Method Suhesti, Tuti
Indonesian Journal of Pharmacy Vol 20 No 3, 2009
Publisher : Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, Skip Utara, 55281, Indonesia

Piroksikam is non steroid anti inflammation drug (NSAID) with small dose (10-20 mg daily) with a long time (t1/2) elimination. Piroxicam formulation was expected able to yield a good (quality) tablet to physical characteristic standard. Tablet r component was consisted of Flowlac 100 (filler), Avicel PH-101 (binder) and Compritol 888 ATO (lubricant).The research was done with simplex lattice design (SLD) by using 3 component, i.e. Flowlac (A), Avicel (B), and Compritol (C). Seven formula were needed, I,e, F1 (100 % A), F2 (100 % B), F3 (100 % C), F4 (50 % A and 50 % B), F5 (50 % B and 50 % C), F6 (50 % A and 50 % C),dan F7 (33.33% A, 33.33 % B, 33.33 % C). The optimization parameters of piroxicam tablets were flow rate of the tablet mass, tablet hardness, disintegration time, piroxicam content and the dissolution (C45), on SLD model; equations, contour plots, and superimposed of contour plots were obtained, by which the optimum formula was determined.Based on superimposed contour plot optimum formula was obtained with proportion of Flowlac (89.6 %), Avicel (7.4 %) and Compritol (3 %). The result of flowability was 21.46 g/second; hardness (6.46 kg); disintegration time (6.98 minutes); drug content (10.13 mg) and dissolution C45 (7.35 mg) Interaction of Flowlac-Avicel-Compritol could influence the physical properties and the release profile of tablet. Flowlac was the most dominant factor in increasing flowability, hardness and dissolution of tablet. Compritol was the most dominant factor in increating time of disintegration tablet.Key words: optimization; piroxicam; simplex lattice design.

Formulation of Gel Hand Sanitizer of Nagasari Leaf Extract (Mesua ferrea L.) Tuti Sri Suhesti; M. Mudrik H. Rohman; Sunarto Sunarto
Indonesian Journal of Pharmaceutical Science and Technology Suppl. 3, No. 1 (2021)
Publisher : Indonesian Journal of Pharmaceutical Science and Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/ijpst.v1i1.36465

Nagasari (Mesua ferrea L.) is one of the biodiversity to be developed as an antiseptic preparation. These plants are known to contain flavonoid compounds, tannins, and terpenoids that act as antibacterial. Hand sanitizer gel preparations can increase the effectiveness of topically. The physical properties of a good gel depend on a gelling agent, one of which is HPMC. The purpose of this study was to determine the effect of variations in HPMC levels on physical properties and antibacterial activity. Gels were prepared with various HPMC levels of 1%, 2%, and 3%. The gel was tested for physical properties and stability. All formulas produced preparations that met the requirements for good physical properties and stability. Testing of antibacterial activity against Staphylococcus aureus showed that an increase in HPMC levels could decrease the ability to release the active substance of the preparation. The diameter of the inhibition zone obtained was 10.0 mm (HPMC 1%); 9.5 mm (2% HPMC) and 8.0 mm (3% HPMC). Increasing the concentration of HPMC will increase the viscosity and adhesion but decrease the spreadability. The three formulas had antibacterial activity against Staphylococcus aureus with moderate criteria.Keywords: Extract of nagasari leaf, Gel, HPMC, Staphylococcus aureus

Optimization of piroxicam tablet formula using flowlac, avicel and compritol by Simplex Lattice Design Method Tuti Sri Suhesti; Achmad Fudholi
Indonesian Journal of Pharmacy Vol 20 No 3, 2009
Publisher : Faculty of Pharmacy Universitas Gadjah Mada, Yogyakarta, Skip Utara, 55281, Indonesia

Piroksikam is non steroid anti inflammation drug (NSAID) with small dose (10-20 mg daily) with a long time (t1/2) elimination. Piroxicam formulation was expected able to yield a good (quality) tablet to physical characteristic standard. Tablet r component was consisted of Flowlac 100 (filler), Avicel PH-101 (binder) and Compritol 888 ATO (lubricant).The research was done with simplex lattice design (SLD) by using 3 component, i.e. Flowlac (A), Avicel (B), and Compritol (C). Seven formula were needed, I,e, F1 (100 % A), F2 (100 % B), F3 (100 % C), F4 (50 % A and 50 % B), F5 (50 % B and 50 % C), F6 (50 % A and 50 % C),dan F7 (33.33% A, 33.33 % B, 33.33 % C). The optimization parameters of piroxicam tablets were flow rate of the tablet mass, tablet hardness, disintegration time, piroxicam content and the dissolution (C45), on SLD model; equations, contour plots, and superimposed of contour plots were obtained, by which the optimum formula was determined.Based on superimposed contour plot optimum formula was obtained with proportion of Flowlac (89.6 %), Avicel (7.4 %) and Compritol (3 %). The result of flowability was 21.46 g/second; hardness (6.46 kg); disintegration time (6.98 minutes); drug content (10.13 mg) and dissolution C45 (7.35 mg) Interaction of Flowlac-Avicel-Compritol could influence the physical properties and the release profile of tablet. Flowlac was the most dominant factor in increasing flowability, hardness and dissolution of tablet. Compritol was the most dominant factor in increating time of disintegration tablet.Key words: optimization; piroxicam; simplex lattice design.

Optimizing effervescent granules of blue pea (Clitoria ternatea L) flower ethanol extract as antioxidant Tuti Sri Suhesti; Warsinah Warsinah; Pitra Wulandari
Acta Pharmaciae Indonesia : Acta Pharm Indo Vol 10 No 1 (2022): Acta Pharmaciae Indonesia : Acta Pharm Indo
Publisher : Pharmacy Department, Faculty of Health Sciences, Jenderal Soedirman University, Purwokerto, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20884/1.api.2022.10.1.5803

Background: Blue pea (Clitoria ternatea) contains secondary metabolites, including flavonoids, saponins, terpenoids, tannins, and anthocyanins which have antioxidant activity. Objective: This research aims to produce the effervescent granule preparations of the blue pea flower ethanol extract with the optimal concentrations of citric acid and tartaric acid. Methods: Blue pea flower was extracted using 70% ethanol. Effervescent granules were made using the wet granulation method in eight formulas containing citric acid and tartaric acid. The physical properties of granules were evaluated, including extract quality, flow rate, dissolution time, and pH. Results: The concentration of the mixed components of citric acid 48.65 mg and tartaric acid 576.30 mg was the most optimal combination of acid sources for effervescent granules of blue pea flower extract with a desirability value of 1,000. Conclusion: The variation in the concentration of citric acid and tartaric acid affected the effervescent granule preparation's flow rate, dissolution time, and pH.

EKSTRAK DAUN PILADANG (Solenostemon scutellarioides (l.) codd) MENURUNKAN KADAR PROCALCITONIN DAN FGF-2 SALIVA PADA TIKUS WISTAR MODEL PERIODONTITIS KRONIS Christiana Cahyani Prihastuti; Ario Ditto Primandaru; A Haris Budi Widodo; Tuti Sri Suhesti; Fanni Kusuma Djati; Amilia Ramadhani; Rinawati Satrio
Mandala Of Health Vol 16 No 1 (2023): Mandala of Health
Publisher : Fakultas Kedokteran Universitas Jenderal Soedirman

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20884/1.mandala.2023.16.1.8386

Periodontitis kronis merupakan inflamasi jaringan periodontal yang disebabkan oleh biofilm bakteri plak dan ditandai dengan pembentukan poket periodontal, resesi gingiva, resorpsi tulang alveolar yang berakibat pada kegoyangan gigi. Perawatan utama periodontitis kronis adalah scaling root planing (SRP) untuk menghilangkan bakteri sebagai etiologi utama namun seringkali membutuhkan terapi adjuvant. Pengembangan terapi adjuvant dari bahan alami diharapkan dapat mengurangi efek samping, salah satunya daun piladang yang diketahui mengandung senyawa aktif seperti flavonoid, saponin, serta tanin. Penelitian ini bertujuan untuk mengetahui pengaruh ekstrak daun piladang terhadap kadar procalcitonin dan fibroblast growth factor-2 (FGF-2) saliva pada tikus model periodontitis kronis. Dua puluh lima tikus Wistar jantan 2-3 bulan, berat badan 150-200 gram dan dibagi menjadi 5 kelompok, yaitu kelompok periodontitis kronis dengan perlakuan ekstrak daun piladang dosis 150 mg/kg BB, 300 mg/kg BB, dan 600 mg/kg BB (P1, P2, P3), kelompok periodontitis kronis dengan perlakuan Na-CMC 1% (kontrol negatif/ KN), serta kontrol sehat (KS). Perlakuan selama tiga hari dilanjutkan pengambilan sampel saliva pada hari ke-empat. Kadar procalcitonin dan FGF-2 saliva diukur dengan uji ELISA. Analisis statistic menggunakan uji One-Way Anova dilanjutkan Post hoc LSD. Hasil menunjukkan penurunan kadar procalcitonin dan FGF-2 saliva pada kelompok perlakuan ekstrak daun piladang (P1, P2, P3) seiring peningkatan konsentrasi ekstrak, berbeda signifikan daripada kontrol negatif (p≤0,05), dan menyamai kondisi sehat (p>0,05). Hal ini mengindikasikan ekstrak daun piladang dapat mempercepat fase inflamasi dan proliferasi pada tikus model periodontitis kronis.

Impact of Donor Age on Human Platelet Lysate Quality and its Consequential Effects on HeLa Cell Growth in the Presence of Anti-Cancer Compounds Diani Mentari; Gratiana Ekaningsih Wijayanti; Tuti Sri Suhesti; Katon Muhammad; Ni Ken Ritchie; Diah Nurpratami
Indonesian Journal of Cancer Chemoprevention Vol 14, No 3 (2023)
Publisher : Indonesian Society for Cancer Chemoprevention

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14499/indonesianjcanchemoprev14iss3pp189-198

An integral aspect of anticancer experimentation involves delineating the optimal dosage of the test compound to ascertain its efficacy in targeting malignant cells. Numerous variables may influence a compound's cytotoxicity, among which is the choice of cell culture medium. Within in vitro settings, supplementary mediums are employed to foster cellular proliferation. Platelet lysate (PL) serves as a growth supplement, presenting an alternative to fetal bovine serum (FBS), primarily due to its incorporation of growth factors such as platelet-derived growth factor (PDGF), a component absents in FBS. The integrity of PL may be subject to various factors, including the age of the donor. This study sought to evaluate the impact of donor age on PL quality. Furthermore, it aimed to discern whether PL derived from platelet concentrate (PC) blood components of different age cohorts influences the IC50 value in anticancer compound assessment. Expired PCs were utilized, subsequently classified into age categories: ≤30 years, >30 years, and a combination of ages. PL analysis encompassed parameters such as pH, blood profile, protein, glucose, and cholesterol levels. The investigation scrutinized the influence of PL quality, as a cellular growth supplement, on the anticancer compound cisplatin's activity against HeLa cells. Findings indicate that donor age influenced the IC50 value of cisplatin on HeLa cells. Notably, elevated cholesterol levels and decreased pH in PL from donor ages >30 years were associated with reduced cisplatin toxicity.Keywords: Cisplatin, Donor Age, HeLa, IC50, Platelet Lysate.

Identifikasi Interaksi Obat Pada Pasien Stroke di Unit Stroke Rumah Sakit Umum Daerah Banyumas Nurmahmudah, Nurmahmudah; Suhesti, Tuti Sri; Utami, Esti Dyah
Acta Pharmaciae Indonesia : Acta Pharm Indo Vol 4 No 1 (2016): Acta Pharmaciae Indonesia : Acta Pharm Indo
Publisher : Pharmacy Department, Faculty of Health Sciences, Jenderal Soedirman University, Purwokerto, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar

Pasien stroke sering memperoleh lebih dari dua macam obat sehingga meningkatkan kemungkinan terjadinya interaksi obat. Penelitian ini bertujuan untuk mengetahui kejadian interaksi obat pada pasien stroke rawat inap di unit stroke RSUD Banyumas berdasarkan buku Drug Interaction Facts. Penelitian ini merupakan penelitian deskriptif evaluatif yang bersifat retrospektif. Pengambilan sampel dilakukan secara total sampling. Data dianalisis secara deskriptif dan disajikan dalam bentuk data kuantitatif dan kualitatif. Hasil penelitian menunjukkan bahwa dari 62 pasien stroke terdapat 26% pasien yang mengalami interaksi obat. Jumlah interaksi obat yang paling banyak terjadi adalah 1 jenis interaksi obat (74%). Jenis interaksi obat yang sering terjadi pada pasien stroke yaitu interaksi obat antara Angiotensin Converting Enzyme Inhibitor (ACEI) dengan KCl sebanyak 18,18%. Mekanisme interaksi obat yang paling banyak terjadi adalah unknown (36%). Tingkat signifikansi 4 paling banyak terjadi yaitu 50%, dengan onset interaksi obat adalah delayed (57%) dan tingkat keparahan moderate yaitu sebanyak 57%. Dokumentasi interaksi obat yang paling banyak terjadi adalah possible (50%).

Optimizing effervescent granules of butterfly pea (Clitoria ternatea L) flower ethanol extract as antioxidant Suhesti, Tuti Sri; Warsinah, Warsinah; Wulandari, Pitra
Acta Pharmaciae Indonesia : Acta Pharm Indo Vol 10 No 1 (2022): Acta Pharmaciae Indonesia : Acta Pharm Indo
Publisher : Pharmacy Department, Faculty of Health Sciences, Jenderal Soedirman University, Purwokerto, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20884/1.api.2022.10.1.5803

Background: Butterfly pea (Clitoria ternatea) contains secondary metabolites, including flavonoids, saponins, terpenoids, tannins, and anthocyanins which have antioxidant activity. Objective: This research aims to produce the effervescent granule preparations of the butterfly pea flower ethanol extract with the optimal concentrations of citric acid and tartaric acid. Methods: Butterfly pea flower was extracted using 70% ethanol. Effervescent granules were made using the wet granulation method in eight formulas containing citric acid and tartaric acid. The physical properties of granules were evaluated, including extract quality, flow rate, dissolution time, and pH. Results: The concentration of the mixed components of citric acid 48.65 mg and tartaric acid 576.30 mg was the most optimal combination of acid sources for effervescent granules of butterfly pea flower extract with a desirability value of 1,000. Conclusion: The variation in the concentration of citric acid and tartaric acid affected flow rate, dissolution time, and pH of the effervescent granule preparation.

Title

Found 16 Documents
Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title Search

Found 16 Documents Search

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Title

Found 16 Documents
Search